| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $885.7M | +7.1% | +28.4% |
| Cost of Revenue | $176.5M | +6.3% | +28.1% |
| Gross Profit | $709.2M | +7.3% | +28.4% |
| R&D Expense | $402.0M | +3.7% | +37.8% |
| SG&A Expense | $74.3M | +6.5% | +41.8% |
| Operating Income | -$5.8M | +83.6% | -128.6% |
| Interest Expense | $1.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $540.6M | +10.5% | +60.2% |
| Accounts Receivable | $549.6M | -9.0% | +12.8% |
| Current Assets | $4.84B | +4.2% | +27.7% |
| Total Assets | $6.05B | +4.0% | +30.7% |
| Current Liabilities | $1.32B | -2.4% | -25.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $723.1M | — | — |
| Capital Expenditures | $40.7M | — | — |
| Investing Cash Flow | -$836.6M | — | — |
| Financing Cash Flow | -$602.5M | — | — |
| Free Cash Flow | $682.4M | — | — |
| -43.6% |
| -8.7% |
| Pre-tax Income | $35.7M | +485.9% | -36.5% |
| Income Tax | $1.8M | -48.2% | -59.9% |
| Net Income | $33.9M | +1180.1% | -34.5% |
| EPS (Basic) | $0.10 | +900.0% | -33.3% |
| EPS (Diluted) | $0.10 | +900.0% | -28.6% |
| $2.61B |
| -0.5% |
| +30.5% |
| Stockholders' Equity | $3.44B | +7.6% | +30.8% |